APA (7th ed.) Citation

Harter, P., Johnson, T., Berton-Rigaud, D., Park, S., Friedlander, M., del Campo, J. M., . . . Jobanputra, M. (2016). BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study. Gynecologic Oncology, 140(3), 443. https://doi.org/10.1016/j.ygyno.2015.12.027

Chicago Style (17th ed.) Citation

Harter, Philipp, et al. "BRCA1/2 Mutations Associated with Progression-free Survival in Ovarian Cancer Patients in the AGO-OVAR 16 Study." Gynecologic Oncology 140, no. 3 (2016): 443. https://doi.org/10.1016/j.ygyno.2015.12.027.

MLA (9th ed.) Citation

Harter, Philipp, et al. "BRCA1/2 Mutations Associated with Progression-free Survival in Ovarian Cancer Patients in the AGO-OVAR 16 Study." Gynecologic Oncology, vol. 140, no. 3, 2016, p. 443, https://doi.org/10.1016/j.ygyno.2015.12.027.